威罗菲尼是由Plexxikon（现在是Daiichi-Sankyo的一部分）和Genentech公司开发的用于治疗晚期黑色素瘤的B-Raf酶抑制剂。
(4-Chlorophenyl)boronic acid
2,6-Difluoro-3-(propylsulfonamido)benzoic acid
5-(4-Chlorophenyl)-1H-pyrrolo[2,3-b]pyridine
2,6-Dichlorobenzoyl Chloride
Ethynyltrimethylsilane
Propane-1-sulfonyl chloride
N-(3-(5-Bromo-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide
5-Bromopyridin-2-amine
(3-Amino-2,6-difluorophenyl)(5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)methanone
5-(4-Chlorophenyl)pyridin-2-amine
Benzyl 2,6-difluoro-3-(propylsulfonamido)benzoate
N-(2,4-Difluoro-3-formylphenyl)propane-1-sulfonamide
3-Bromo-5-(4-chlorophenyl)pyridin-2-amine
Benzyl 3-amino-2,6-difluorobenzoate
5-(4-Chlorophenyl)-3-iodopyridin-2-amine
N-(3-(5-(4-Chlorophenyl)-1-(2,6-dichlorobenzoyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide
N-(2,4-Difluorophenyl)propane-1-sulfonamide
N-(3-(5-Bromo-1-(2,6-dichlorobenzoyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide
2,6-Difluoro-3-nitrobenzoyl chloride
2-(2-Ethoxyvinyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
(3-(3-Amino-2,6-difluorobenzoyl)-5-bromo-1H-pyrrolo[2,3-b]pyridin-1-yl)(2,6-dichlorophenyl)methanone
(5-Bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)(2,6-difluoro-3-nitrophenyl)methanone
